Barrington, Illinois Clinical Trials

A listing of Barrington, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 72 clinical trials
A Study to Assess the Safety Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

The purpose of this study is to evaluate the effect of IONIS-AGT-LRx compared to placebo on systolic blood pressure (SBP) from baseline to Study Day 85 in uncontrolled hypertensive participants on 3 antihypertensive medications and to evaluate the effect of IONIS-AGT-LRx on SBP, diastolic blood pressure (DBP) and plasma angiotensinogen …

angiotensin
body mass index
systolic blood pressure
calcium
angiotensin ii
Clinical Investigation Specialists, Inc. - Wauconda
 (7.5 away) Contact site
  • 0 views
  • 26 Sep, 2021
  • +38 other locations
A Clinical Study to Evaluate the Safety and Efficacy of the Optilume BPH Catheter System in Men With Symptomatic BPH

PINNACLE is a prospective, multi-center, randomized control clinical trial to establish the safety and efficacy of the Optilume BPH Catheter System in the treatment of benign prostatic hyperplasia (BPH)

benign prostatic hypertrophy
paclitaxel
medical therapy
transrectal ultrasound
hyperplasia
Comprehensive Urologic Care
 (3.8 away) Contact site
  • 521 views
  • 07 May, 2021
  • +22 other locations
Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Subjects With Castration Resistant Prostate Cancer Who Have Not Received Chemotherapy

A phase 1b/2 study to examine taz in combination with enz or abi/pred in patients with metastic castration resistant prostate cancer

medical castration
apalutamide
enzalutamide
progressive disease
gonadotropin
XCancer - Northwest Oncology and Hematology
 (9.0 away) Contact site
  • 98 views
  • 10 Jul, 2021
  • +31 other locations
Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)

This is a multicenter, longitudinal, single-arm, open-label study to describe the change from baseline in cognitive processing speed, measured by the SDMT, in subjects with RMS treated with ozanimod HCl 1 mg at 3 years. All subjects will receive orally administered ozanimod HCl 1 mg. The primary efficacy endpoint is …

relapsing multiple sclerosis
Northwest Neurology, Ltd
 (7.9 away) Contact site
  • 132 views
  • 25 Aug, 2021
  • +83 other locations
MILD Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as well as harms associated with the MILD procedure, at 24 months post-treatment with MILD, tested against a control group of similar patients that have had a comparable procedure. This study …

AMITA Health St. Alexius Medical Center Hoffman Estates
 (7.2 away) Contact site
  • 13680 views
  • 26 Sep, 2021
  • +897 other locations
OEIS Outcome Data Registry

This registry is created under the sponsorship of the Outpatient Endovascular and Interventional Society (OEIS) to monitor the clinical course and treatment outcomes of patients undergoing office-based endovascular procedures.

vascular disease
endovascular procedure
Outpatient Endovascular Interventional Society (OEIS)
 (7.9 away) Contact site
  • 9 views
  • 22 Jan, 2021
  • 1 location
MammaPrint BluePrint and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study …

Saint Alexius Medical Center
 (7.9 away) Contact site
  • 706 views
  • 28 May, 2021
  • +111 other locations
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

The objectives of this study are to describe characteristics, treatment patterns, and outcomes of patients with schizophrenia newly initiated on 1 of 4 FDA-approved atypical Long Acting Injectable (LAI) antipsychotics (ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA or RISPERDAL CONSTA)

antipsychotics
risperdal
abilify
Alkermes Investigational Site
 (9.2 away) Contact site
  • 109 views
  • 11 May, 2021
  • +50 other locations
Psoriasis Longitudinal Assessment and Registry

The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient and disease characteristics, including patient-reported …

brodalumab
psoralen
methotrexate
guselkumab
cyclosporine
Altman Dermatology Associates
 (9.0 away) Contact site
  • 4040 views
  • 07 Sep, 2021
  • +493 other locations
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

This study will develop an algorithm of identifying patients with stage IV NSCLC and Melanoma who could benefit from cancer treatment they receive.

platelet count
neutrophil count
cancer
measurable disease
Northwest Community Healthcare
 (9.0 away) Contact site
  • 0 views
  • 10 Aug, 2021
  • +31 other locations